Stay updated on Pemetrexed Maintenance & ADXS11-001 Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the Pemetrexed Maintenance & ADXS11-001 Immunotherapy Clinical Trial page.

Latest updates to the Pemetrexed Maintenance & ADXS11-001 Immunotherapy Clinical Trial page
- Check6 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2; no substantive changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check34 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0 from the page; study details remain unchanged.SummaryDifference0.1%

- Check41 days agoChange DetectedRemoved the site-wide banner about government funding lapse and NIH operations from the Study Details page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check56 days agoChange DetectedNo additions or deletions were observed between the two screenshots; the study details page content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check84 days agoChange DetectedPage now includes a new government funding status notice and NIH Clinical Center operating details, and updates the Revision from v3.1.0 to v3.2.0.SummaryDifference5%

Stay in the know with updates to Pemetrexed Maintenance & ADXS11-001 Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pemetrexed Maintenance & ADXS11-001 Immunotherapy Clinical Trial page.